Tag:
tonabersat
Latest Headlines
Latest Headlines
Minster Pharma shares in meltdown on trial failure
Shares of the UK's Minster Pharmaceuticals went into free fall this morning, losing 63 percent of their value after the developer announced that its migraine drug tonabersat failed a Phase IIb trial.
